Megan Walz is the Process Engineer at Kriya Therapeutics. Ms. Walz joins Kriya from bluebird bio, where she was a Manufacturing Associate and then Engineer. Ms. Walz was part of the team involved in the construction and start-up of bluebird bio’s first internal manufacturing facility and was responsible for preparing the facility for GMP manufacturing. Prior to bluebird bio, Ms. Walz was a Research Associate in a microbial fermentation process development group at Novozymes and spent time as a Research Assistant at bioMASON.
Ms. Walz received her master’s degree in biological systems engineering from the University of Kentucky and her undergraduate degree in biology from North Carolina State University.